Orhan KÜÇÜKŞAHİN, Batuhan TURGAY, İsmail UÇAR, Murat TURGAY, Esma ÖZKAN UÇAR

Sexual dysfunction in patients with systemic sclerosis

Background/aim: The aim of the study was to investigate the effect of systemic sclerosis (SSc) on quality of life and sexual function infemale patients.Materials and methods: The study included 30 sexually active female patients with SSc and 30 healthy control subjects. For allparticipants in both the patient and control groups, the female sexual index and SF-36 forms were completed and a detailed medicaland sexual history was taken.Results: The mean age was 45.03 ± 9.22 years in the SSc group and 44.6 ± 11.52 years in the control group (P = 0.87). The SF-36 scoresin the patient group were significantly lower than those in the control group. Sexual dysfunction was found in 26/30 (86.6%) of the SScpatients and in 6/30 (20%) of the control group (P = 0.0001). Significant differences were determined between the groups with respectto sexual desire, arousal, lubrication, orgasm, sexual satisfaction, and pain. There was no significant relationship between the subgroupsof SSc patients, duration of disease, lung involvement, and FSFI scores.Conclusion: Sexual dysfunction and lower health quality are common problems in female patients with systemic sclerosis.

PDF

___

White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin N Am 1996; 22: 695-708.
Denton CP, Black CM. Scleroderma clinical and pathological advances. Best Pract Res Cl Rh 2004; 18: 271-290.
Krieg T, Meurer M. Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol 1988; 18: 457- 481.
Varga J. Systemic sclerosis: an update. Bull NYU Hosp Jt Dis 2007; 66: 198-202.
Hong P, Pope JE, Ouimet JM, Rullan E. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 2004; 31: 508-513.
Simeon C, Fonollosa V, Vilardell M. Impotence and Peyronie’s disease in systemic sclerosis. Clin Exp Rheumatol 1994; 12: 464-464.
Walker U, Tyndall A, and Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis 2009; 68: 1083-1085.
Lally EV and Jimenez SA. Impotence in progressive systemic sclerosis. Ann Intern Med 1981; 95: 150-153.
Nowlin NS, Brick JE, Weaver DJ. Impotence in scleroderma. Ann Intern Med 1986; 104: 794-798.
Aversa A, Proietti M, Bruzziches R. Case report: the penile vasculature in systemic sclerosis: a duplex ultrasound study. J Sex Med 2006; 3: 554-558.
Merla A, Romani GL, Tangherlini A. Penile cutaneous temperature in systemic sclerosis: a thermal imaging study. Int J Immunopath Ph 2006; 20:139-144.
Bhadauria S, Moser DK, Clements PJ, Singh RR. Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am J Obstet Gynecol 1995; 172: 580-587.
Saad SC and Behrendt AE. Scleroderma and sexuality. J Sex Res 1996; 33: 215-220.
Trilpell L, Nietert P and Brown A. Prevalence of female sexual dysfunction among women with systemic sclerosis. In: Proceedings of the 9th International Workshop on Scleroderma Research 2006; Boston, MA, USA; 5–9 August 2006.
Oksuz E and Malhan S. Reliability and validity of the Female Sexual Function Index in the Turkish population. Sendrom 2005; 17: 54-60.
Mayes MD. Scleroderma epidemiology. Rheum Dis Clin N Am 1996; 22: 751-764.
Impens AJ, Rothman J, Schiopu E. Sexual activity and functioning in female scleroderma patients. Clin Exp Rheumatol 2009; 27: S38.
Schouffoer AA, Van Der Marel J. Impaired sexual function in women with systemic sclerosis: a cross‐sectional study. Arthrit Care Res 2009; 61: 1601-1608.
Levis B, Hudson M, Knafo R, Baron M. Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthrit Care Res 2012; 64: 340-350.